Letter: direct-acting anti-viral (DAA) therapy needs strong safety and efficacy check-authors' reply.
Saved in:
| Title: | Letter: direct-acting anti-viral (DAA) therapy needs strong safety and efficacy check-authors' reply. |
|---|---|
| Authors: | Singer AW; Gilead Sciences Inc., Foster City, CA, USA., Reddy KR; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Telep LE; Gilead Sciences Inc., Foster City, CA, USA., Osinusi AO; Gilead Sciences Inc., Foster City, CA, USA., Brainard DM; Gilead Sciences Inc., Foster City, CA, USA., Buti M; Hospital General Universitari Vall d'Hebron, Barcelona, Spain., Chokkalingam AP; Gilead Sciences Inc., Foster City, CA, USA.; School of Public Health, University of California, Berkeley, CA, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Jul; Vol. 48 (2), pp. 235-236. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.14820 |
